JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Compare Kidney Cancer medicines

Compare Kidney Cancer medicines

Afinitor (everolimus) vs Fotivda (tivozanib)

Afinitor (everolimus) vs Inlyta (axitinib)

Bavencio (avelumab) vs Afinitor (everolimus)

Bavencio (avelumab) vs Fotivda (tivozanib)

Bavencio (avelumab) vs Inlyta (axitinib)

Bavencio (avelumab) vs Lenvima (lenvatinib)

Bavencio (avelumab) vs Vegzelma (bevacizumab-adcd)

Cabometyx (cabozantinib) vs Afinitor (everolimus)

Cabometyx (cabozantinib) vs Bavencio (avelumab)

Cabometyx (cabozantinib) vs Fotivda (tivozanib)

Cabometyx (cabozantinib) vs Inlyta (axitinib)

Cabometyx (cabozantinib) vs Vegzelma (bevacizumab-adcd)

Fotivda (tivozanib) vs Inlyta (axitinib)

Fotivda (tivozanib) vs Vegzelma (bevacizumab-adcd)

Inlyta (axitinib) vs Vegzelma (bevacizumab-adcd)

Keytruda (pembrolizumab) vs Cabometyx (cabozantinib)

Keytruda (pembrolizumab) vs Fotivda (tivozanib)

Keytruda (pembrolizumab) vs Inlyta (axitinib)

Keytruda (pembrolizumab) vs Lenvima (lenvatinib)

Lenvima (lenvatinib) vs Afinitor (everolimus)

Lenvima (lenvatinib) vs Fotivda (tivozanib)

Lenvima (lenvatinib) vs Inlyta (axitinib)

Lenvima (lenvatinib) vs Vegzelma (bevacizumab-adcd)

Opdivo (Nivolumab) vs Cabometyx (cabozantinib)

Opdivo (Nivolumab) vs Fotivda (tivozanib)

Opdivo (Nivolumab) vs Inlyta (axitinib)

LV Latvia 1